{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:02:06Z","timestamp":1791511326323,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.virusres.2026.199750","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:39:34Z","timestamp":1779259174000},"page":"199750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting NF-\u03baB signaling for HIV latency reversal: Mechanisms, challenges, and therapeutic perspectives"],"prefix":"10.1016","volume":"369","author":[{"given":"Maryam Mashhadi Abolghasem","family":"Shirazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7739-179X","authenticated-orcid":false,"given":"Seyed Mehdi","family":"Sadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.virusres.2026.199750_bib0001","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038768","article-title":"Toward a cure\u2013advancing HIV\/AIDs treatment modalities beyond antiretroviral therapy: a review","volume":"103","author":"Alum","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.virusres.2026.199750_bib0002","series-title":"Proceedings of the National Academy of Sciences","first-page":"11698","article-title":"Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo","volume":"110","author":"Beans","year":"2013"},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/srep39032","article-title":"In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation","volume":"6","author":"Brogdon","year":"2016","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.virusres.2026.199750_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00491-18","article-title":"Antiviral activity of HIV gp120-targeting bispecific T cell engager antibody constructs","volume":"92","author":"Brozy","year":"2018","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2026.199750_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.virusres.2026.199750_bib0006","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI80565","article-title":"Molecular mechanisms of HIV latency","volume":"126","author":"Cary","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/COH.0b013e32834124fd","article-title":"NF-\u03baB\/rel: agonist and antagonist roles in HIV-1 latency","volume":"6","author":"Chan","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virusres.2026.199750_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1354502","article-title":"Dynamic modulation of the non-canonical NF-\u03baB signaling pathway for HIV shock and kill","volume":"14","author":"Chandrasekar","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.virusres.2026.199750_bib0009","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.7150\/thno.73223","article-title":"Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.virusres.2026.199750_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/imo2.31","article-title":"Commentary on LRAs targeting NF-\u03baB with epigenetic and mutational impacts on HIV latency","volume":"1","author":"Chen","year":"2024","journal-title":"iMetaOmics"},{"issue":"6","key":"10.1016\/j.virusres.2026.199750_bib0011","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/v12060609","article-title":"Debnath AK. Identification of combinations of protein kinase C activators and histone deacetylase inhibitors that potently reactivate latent HIV","volume":"12","author":"Curreli","year":"2020","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.virusres.2026.199750_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+ JQ1 and ingenol-B+ JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2026.199750_bib0013","series-title":"Generation and Efficacy Analysis of a Bispecific Nanobody Targeting CD8+ T cells and HIV-infected Cells","author":"Debaveye","year":"2022"},{"key":"10.1016\/j.virusres.2026.199750_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113937","article-title":"4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC\/MEK activation synergizing with vorinostat","volume":"177","author":"De la Torre-Tarazona","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.virusres.2026.199750_bib0015","article-title":"HIV Latency: novel insights into the viral reservoir and therapeutic strategies","author":"de Oliveira","year":"2024","journal-title":"Front. Media SA;"},{"key":"10.1016\/j.virusres.2026.199750_bib0016","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fimmu.2018.01514","article-title":"In vitro exposure to prostratin but not bryostatin-1 improves natural killer cell functions including killing of CD4+ T cells harboring reactivated human immunodeficiency virus","volume":"9","author":"Desimio","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.virusres.2026.199750_bib0017","doi-asserted-by":"crossref","first-page":"e5184","DOI":"10.1002\/pro.5184","article-title":"Biophysical characterization of RelA\u2013p52 NF-\u03baB dimer\u2014A link between the canonical and the non-canonical NF-\u03baB pathway","volume":"33","author":"Dhaka","year":"2024","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0018","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41467-025-57290-y","article-title":"Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency","volume":"16","author":"Dorman","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.virusres.2026.199750_bib0019","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157281","article-title":"Combined noncanonical NF-\u03baB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo","volume":"132","author":"Falcinelli","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.virusres.2026.199750_bib0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/infdis\/jiad423","article-title":"The effects of human immunodeficiency virus type 1 (HIV-1) antigen-expanded specific T-cell therapy and vorinostat on persistent HIV-1 infection in people with HIV on antiretroviral therapy","volume":"229","author":"Gay","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.virusres.2026.199750_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01953-21","article-title":"Bryostatin-1 decreases HIV-1 infection and viral production in human primary macrophages","volume":"96","author":"Hany","year":"2022","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0023","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s44466-025-00014-0","article-title":"NF-\u03baB: master regulator of cellular responses in health and disease","volume":"1","author":"Hoffmann","year":"2025","journal-title":"Immunity Inflamm."},{"issue":"2","key":"10.1016\/j.virusres.2026.199750_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012874","article-title":"Activating PKC-\u03b5 induces HIV expression with improved tolerability","volume":"21","author":"Irrinki","year":"2025","journal-title":"PLoS. Pathog."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/aid.2014.0199","article-title":"Targeting NF-\u03baB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency","volume":"31","author":"Jiang","year":"2015","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"11","key":"10.1016\/j.virusres.2026.199750_bib0026","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/QAD.0000000000000289","article-title":"Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase c\u03b4\u2013NF-\u03baB signaling","volume":"28","author":"Jiang","year":"2014","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.virusres.2026.199750_bib0027","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/pharmaceutics13111748","article-title":"Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials","volume":"13","author":"Kawano","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.virusres.2026.199750_bib0028","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/17460441.2024.2305730","article-title":"Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents","volume":"19","author":"Khatun","year":"2024","journal-title":"Expert. Opin. Drug Discov."},{"issue":"5","key":"10.1016\/j.virusres.2026.199750_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101864","article-title":"Regulatory subunit NEMO promotes polyubiquitin-dependent induction of NF-\u03baB through a targetable second interaction with upstream activator IKK2","volume":"298","author":"Ko","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.virusres.2026.199750_bib0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/v16050666","article-title":"Post-transcriptional HIV-1 latency: a promising target for therapy?","volume":"16","author":"Kobayashi-Ishihara","year":"2024","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.virusres.2026.199750_bib0031","article-title":"A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection","volume":"6","author":"Kroon","year":"2020","journal-title":"J. Virus. Erad."},{"issue":"2","key":"10.1016\/j.virusres.2026.199750_bib0032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1570162X17666190618160608","article-title":"Updated studies on the development of HIV therapeutic vaccine","volume":"17","author":"Larijani","year":"2019","journal-title":"Curr. HIV Res."},{"issue":"7","key":"10.1016\/j.virusres.2026.199750_bib0033","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.ppat.0020068","article-title":"Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells","volume":"2","author":"Lassen","year":"2006","journal-title":"PLoS. Pathog."},{"issue":"4","key":"10.1016\/j.virusres.2026.199750_bib0034","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ymthe.2025.01.048","article-title":"Development of RelB-targeting small-molecule inhibitors of non-canonical NF-\u03baB signaling with antitumor efficacy","volume":"33","author":"Li","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/nar\/gks976","article-title":"The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of tat-transactivation","volume":"41","author":"Li","year":"2013","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.virusres.2026.199750_bib0036","article-title":"HIV-1 latency reversal agent boosting is not limited by opioid use","author":"Lilie","year":"2024","journal-title":"Medrxiv: Preprint Server Health Sci."},{"key":"10.1016\/j.virusres.2026.199750_bib0037","unstructured":"Liu X. An evaluation on the role of non-coding RNA in HIV transcription and latency: a review. arXiv preprint arXiv:250206107. 2025."},{"issue":"18","key":"10.1016\/j.virusres.2026.199750_bib0038","doi-asserted-by":"crossref","first-page":"10803","DOI":"10.1128\/JVI.00320-14","article-title":"The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events","volume":"88","author":"Lucera","year":"2014","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2026.199750_bib0039","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00705-025-06381-8","article-title":"Pharmacological advances in HIV treatment: from ART to long-acting injectable therapies","volume":"170","author":"\u0141upina","year":"2025","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0040","article-title":"HIV-related immune activation and inflammation: current understanding and strategies","volume":"2021","author":"Lv","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.virusres.2026.199750_bib0041","series-title":"Molecular Mechanisms and Host Factors Involved in HIV-1 Latency","author":"Madapuji Srinivasan","year":"2024"},{"key":"10.1016\/j.virusres.2026.199750_bib0042","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2018.05.006","article-title":"Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents","volume":"520","author":"Marsden","year":"2018","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106493","article-title":"Management of comorbidities in treated HIV infection: a long way to go: HIV, comorbidities and aging","volume":"59","author":"Mart\u00ednez-Sanz","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-17196-7","article-title":"Novel bioinformatics approaches to design epitope-based vaccine against HIV latency by inquiring CTL epitopes and built-in adjuvants","volume":"15","author":"Mashhadi Abolghasem Shirazi","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43965-3","article-title":"Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope","volume":"13","author":"Mashhadi Abolghasem Shirazi","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.virusres.2026.199750_bib0046","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.3390\/ijms25052621","article-title":"HIV reservoirs and treatment strategies toward curing HIV infection","volume":"25","author":"Matsuda","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.virusres.2026.199750_bib0047","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01429-20","article-title":"CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed simian immunodeficiency virus-infected rhesus macaques","volume":"95","author":"Mavigner","year":"2021","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.virusres.2026.199750_bib0048","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97071","article-title":"Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment","volume":"2","author":"Mirza","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.virusres.2026.199750_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.780400","article-title":"SMAC mimetics as therapeutic agents in HIV infection","volume":"12","author":"Molyer","year":"2021","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.virusres.2026.199750_bib0050","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.3390\/ijms25189793","article-title":"NF-\u03baB transcription factors: their distribution, family expansion, structural conservation, and evolution in animals","volume":"25","author":"Msweli","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"818","key":"10.1016\/j.virusres.2026.199750_bib0051","doi-asserted-by":"crossref","first-page":"eadh1641","DOI":"10.1126\/scisignal.adh1641","article-title":"The NF-\u03baB signaling system in the immunopathogenesis of inflammatory bowel disease","volume":"17","author":"Mukherjee","year":"2024","journal-title":"Sci. Signal."},{"issue":"903","key":"10.1016\/j.virusres.2026.199750_bib0052","doi-asserted-by":"crossref","first-page":"eado9243","DOI":"10.1126\/scisignal.ado9243","article-title":"Identification of proteins in semen-derived extracellular vesicles that bind to Tat and NF-\u03baB and that may impair HIV replication","volume":"18","author":"Okeoma","year":"2025","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010245","article-title":"The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription","volume":"18","author":"Okoye","year":"2022","journal-title":"PLoS. Pathog."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0054","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/pathogens10010016","article-title":"Balance between retroviral latency and transcription: based on HIV model","volume":"10","author":"Pluta","year":"2020","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.virusres.2026.199750_bib0055","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/glia.23833","article-title":"HIV-1 infection and latency-reversing agents bryostatin-1 and JQ1 disrupt amyloid beta homeostasis in human astrocytes","volume":"68","author":"Proust","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.virusres.2026.199750_bib0056","series-title":"An Evaluation On the Role of Non-Coding RNA in HIV Transcription and latency: a Review","first-page":"115","author":"Ramirez","year":"2023"},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0057","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41540-025-00538-6","article-title":"Mathematical modeling and mechanisms of HIV latency for personalized anti latency therapies","volume":"11","author":"Rasi","year":"2025","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.virusres.2026.199750_bib0058","article-title":"The SMAC mimetic AZD5582 is a potent HIV latency reversing agent","author":"Sampey","year":"2018","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.virusres.2026.199750_bib0059","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00240-24","article-title":"HIV-1 vpr-induced DNA damage activates NF-\u03baB through ATM-NEMO independent of cell cycle arrest","volume":"15","author":"Sandoval","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.virusres.2026.199750_bib0060","unstructured":"Scaglioni S. The role of CD4+ T memory subsets in HIV infection: immune response in people with HIV and latency establishment. 2025."},{"issue":"2","key":"10.1016\/j.virusres.2026.199750_bib0061","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40264-018-0773-9","article-title":"Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology","volume":"42","author":"Shah","year":"2019","journal-title":"Drug Saf."},{"issue":"11","key":"10.1016\/j.virusres.2026.199750_bib0062","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01361-18","article-title":"Synthetic ingenols maximize protein kinase C-induced HIV-1 latency reversal","volume":"62","author":"Spivak","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.virusres.2026.199750_bib0063","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199750_bib0064","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/pathogens14030232","article-title":"Latency reversing agents and the road to an HIV cure","volume":"14","author":"Tioka","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.virusres.2026.199750_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biosystems.2021.104564","article-title":"The canonical and non-canonical NF-\u03baB pathways and their crosstalk: a comparative study based on Petri nets","volume":"211","author":"Trares","year":"2022","journal-title":"Biosystems"},{"issue":"17","key":"10.1016\/j.virusres.2026.199750_bib0066","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01057-20","article-title":"NF-\u03baB-interacting long noncoding RNA regulates HIV-1 replication and latency by repressing NF-\u03baB signaling","volume":"94","author":"Wang","year":"2020","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199750_bib0067","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.emboj.7600900","article-title":"NF-\u03baB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation","volume":"25","author":"Williams","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.virusres.2026.199750_bib0068","first-page":"63","article-title":"NF-\u03baB sub-pathways and HIV cure: a revisit","author":"Wong","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virusres.2026.199750_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104555","article-title":"Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections","volume":"169","author":"Yang","year":"2019","journal-title":"Antiviral Res."},{"issue":"430","key":"10.1016\/j.virusres.2026.199750_bib0070","doi-asserted-by":"crossref","first-page":"eaap9927","DOI":"10.1126\/scitranslmed.aap9927","article-title":"HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing","volume":"10","author":"Yukl","year":"2018","journal-title":"Sci. Transl. Med."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:07:46Z","timestamp":1781615266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":70,"alternative-id":["S0168170226000699"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199750","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting NF-\u03baB signaling for HIV latency reversal: Mechanisms, challenges, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199750"}}